恒生科技指数逆势大跌超3% 大型科技股领跌
格隆汇11月10日丨疫苗迎重磅利好,港股普涨,但此前表现一直强势的港股科技股跟随美股市场科技股普跌,促恒生科技指数逆势大跌超3%。成分股中,比亚迪电子跌超9%领跌,京东、金山软件跌超6%,美团跌超5%,舜宇、网易跌超4%,阿里健康、丘钛科技、小米、阿里巴巴、中兴通讯跌超3%,腾讯跌超2%。隔夜美股市场互联网零售股普跌,阿里巴巴跌超3%,京东跌超8%,拼多多跌超7%,亚马逊、唯品会跌超5%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.